Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk
Blood Cancer Journal, Published online: 22 April 2024; doi:10.1038/s41408-024-01030-wDaratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 22, 2024 Category: Hematology Authors: Natalie S. Callander Rebecca Silbermann Jonathan L. Kaufman Kelly N. Godby Jacob Laubach Timothy M. Schmidt Douglas W. Sborov Eva Medvedova Brandi Reeves Binod Dhakal Cesar Rodriguez Saurabh Chhabra Ajai Chari Susan Bal Larry D. Anderson Jr Bhagirathbhai Source Type: research
Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study
Blood Cancer Journal, Published online: 22 April 2024; doi:10.1038/s41408-024-01052-4Age-stratified analysis reveals arterial thrombosis as a predictor for gender-related second cancers in myeloproliferative neoplasms: a case-control study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 22, 2024 Category: Hematology Authors: Arianna Ghirardi Alessandra Carobbio Paola Guglielmelli Alessandro Rambaldi Valerio De Stefano Alessandro M. Vannucchi Ayalew Tefferi Tiziano Barbui Source Type: research
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody
Blood Cancer Journal, Published online: 18 April 2024; doi:10.1038/s41408-024-01050-6Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 18, 2024 Category: Hematology Authors: Sylwia A. Stefa ńczyk Ilona Hagelstein Martina S. Lutz Stefanie M üller Samuel J. Holzmayer Grace Jarjour Latifa Zekri Jonas S. Heitmann Helmut R. Salih Melanie M ärklin Source Type: research
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme
Blood Cancer Journal, Published online: 15 April 2024; doi:10.1038/s41408-024-01038-2Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 15, 2024 Category: Hematology Authors: Macarena Oporto Espuelas Saskia Burridge Amy A. Kirkwood Denise Bonney Kelly Watts Geoff Shenton Katarzyna A. Jalowiec Maeve A. O ’Reilly Claire Roddie Anna Castleton Katherine Clesham Emma Nicholson Rajesh Alajangi Shilpa Prabhu Lindsay George Ben Utte Source Type: research
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
Blood Cancer Journal, Published online: 15 April 2024; doi:10.1038/s41408-024-01046-2In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 15, 2024 Category: Hematology Authors: Thomas Lund Michael Tveden Gundesen Annette Juul Vangsted Carsten Helleberg Einar Hauk ås Trine Silkj ær Jon Thor Asmussen Elena Manuela Teodorescu Bo Amdi Jensen Tobias Schmidt Sl ørdahl Hareth Nahi Anders Waage Niels Abildgaard Fredrik Schjesvold Source Type: research
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium
Blood Cancer Journal, Published online: 12 April 2024; doi:10.1038/s41408-024-00993-0Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 12, 2024 Category: Hematology Authors: Aimaz Afrough Hamza Hashmi Doris K. Hansen Surbhi Sidana Chul Ahn Lauren C. Peres Danai Dima Ciara L. Freeman Omar Castaneda Puglianini Mehmet H. Kocoglu Shebli Atrash Peter M. Voorhees Leyla Shune Joseph P. McGuirk Gary Simmons Douglas W. Sborov James A. Source Type: research
CD56 expression predicts response to Daratumumab-based regimens
Blood Cancer Journal, Published online: 12 April 2024; doi:10.1038/s41408-024-01051-5CD56 expression predicts response to Daratumumab-based regimens (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 12, 2024 Category: Hematology Authors: Allen J. Robinette Laila Huric Kameron Dona Don Benson Francesca Cottini Source Type: research
Like a bridge over troubled water: keeping the myeloma down en route to CAR-T
Blood Cancer Journal, Published online: 12 April 2024; doi:10.1038/s41408-024-01049-zLike a bridge over troubled water: keeping the myeloma down en route to CAR-T (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 12, 2024 Category: Hematology Authors: Joshua Richter Source Type: research
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms
Blood Cancer Journal, Published online: 09 April 2024; doi:10.1038/s41408-024-01031-9Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 9, 2024 Category: Hematology Authors: Wan-Hsuan Lee Chien-Chin Lin Cheng-Hong Tsai Feng-Ming Tien Min-Yen Lo Mei-Hsuan Tseng Yuan-Yeh Kuo Shan-Chi Yu Ming-Chih Liu Chang-Tsu Yuan Yi-Tsung Yang Ming-Kai Chuang Bor-Sheng Ko Jih-Luh Tang Hsun-I Sun Yi-Kuang Chuang Hwei-Fang Tien Hsin-An Hou Wen- Source Type: research
A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death
Blood Cancer Journal, Published online: 09 April 2024; doi:10.1038/s41408-024-01019-5A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 9, 2024 Category: Hematology Authors: Arghya Ray Ting Du Xueping Wan Yan Song Sindhu C. Pillai Md. Abu Musa Teng Fang Jared Moore Brian Blank Xiaohui Du Xi Chen Robert Warne Dena Sutimantanapi Fang Lui Tatiana Zavorotinskaya Christophe Colas Lori Friedman Melissa R. Junttila Dharminder Chauha Source Type: research
CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications
Blood Cancer Journal, Published online: 09 April 2024; doi:10.1038/s41408-024-01042-6CEBPA bZIP in-frame mutations in acute myeloid leukemia: prognostic and therapeutic implications (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 9, 2024 Category: Hematology Authors: Fenghong Zhang Zhen Shen Jundan Xie Jingren Zhang Qian Wu Rui Jiang Xiangyu Zhao Xiaofei Yang Suning Chen Source Type: research
VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study
Blood Cancer Journal, Published online: 09 April 2024; doi:10.1038/s41408-024-01047-1VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - April 9, 2024 Category: Hematology Authors: Jakob Nordberg N ørgaard Kari Lenita Falck Moore Tobias S. Sl ørdahl Anders Vik Tor Henrik Anderson Tvedt Fredrik Schjesvold Source Type: research
Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial
Blood Cancer Journal, Published online: 27 March 2024; doi:10.1038/s41408-024-01037-3Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 27, 2024 Category: Hematology Authors: Niek G. van der Maas Jurjen Versluis Kazem Nasserinejad Joost van Rosmalen Thomas Pabst Johan Maertens Dimitri Breems Markus Manz Jacqueline Cloos Gert J. Ossenkoppele Yngvar Floisand Patrycja Gradowska Bob L öwenberg Gerwin Huls Douwe Postmus Francesco Source Type: research
How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials?
Blood Cancer Journal, Published online: 26 March 2024; doi:10.1038/s41408-024-00996-xHow comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials? (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 26, 2024 Category: Hematology Authors: Ing Soo Tiong Meaghan Wall Ashish Bajel Akash Kalro Shaun Fleming Andrew W. Roberts Nisha Thiagarajah Chong Chyn Chua Maya Latimer David Yeung Paula Marlton Amanda Johnston Anoop Enjeti Chun Yew Fong Gavin Cull Stephen Larsen Glen Kennedy Anthony Schwarer Source Type: research
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide
Blood Cancer Journal, Published online: 26 March 2024; doi:10.1038/s41408-024-01039-1Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 26, 2024 Category: Hematology Authors: Utkarsh Goel Charalampos Charalampous Prashant Kapoor Moritz Binder Francis K. Buadi David Dingli Angela Dispenzieri Amie Fonder Morie A. Gertz Wilson I. Gonsalves Suzanne R. Hayman Miriam A. Hobbs Yi L. Hwa Taxiarchis Kourelis Martha Q. Lacy Nelson Leung Source Type: research
